{"hands_on_practices": [{"introduction": "Many spinocerebellar ataxias, such as SCA13, are fundamentally channelopathies where mutations alter neuronal excitability. This exercise provides hands-on practice with the Hodgkin-Huxley framework, a cornerstone of computational neuroscience, to model the biophysical impact of a gain-of-function mutation in the $KCNC3$ gene [@problem_id:4527255]. By building and analyzing a simplified neuron model, you will quantify how specific mutational effects on channel conductance and kinetics translate into a measurable change in the action potential repolarization time constant, bridging the gap from a genetic defect to cellular dysfunction.", "problem": "You are asked to design and analyze a minimal biophysical model of the high-voltage activated potassium channel encoded by the potassium voltage-gated channel subfamily C member 3 ($KCNC3$, Kv3.3), which has been implicated in Spinocerebellar Ataxia type 13 (SCA13). Starting from the Hodgkin–Huxley conductance-based framework, consider a single-compartment neuron with membrane capacitance and two ionic currents: a passive leak and a voltage-gated potassium current attributable to $KCNC3$ (Kv3.3). During the action potential repolarization phase, assume that inward sodium currents are negligible. Let the membrane potential be denoted by $V$ (in $\\text{mV}$) and the activation gating variable of the Kv3.3 channel be denoted by $m$ (dimensionless).\n\nUse the following foundational definitions and well-tested relationships:\n- The membrane equation for a single compartment is given by\n$$\nC_m \\frac{dV}{dt} = - g_L \\left(V - E_L\\right) - g_{Kv3}\\, m^p \\left(V - E_K\\right),\n$$\nwhere $C_m$ is the membrane capacitance (in $\\mu \\text{F}/\\text{cm}^2$), $g_L$ is the leak conductance (in $\\text{mS}/\\text{cm}^2$), $E_L$ is the leak reversal potential (in $\\text{mV}$), $g_{Kv3}$ is the maximal Kv3.3 conductance (in $\\text{mS}/\\text{cm}^2$), $E_K$ is the potassium reversal potential (in $\\text{mV}$), and $p$ is a cooperativity exponent.\n- The gating dynamics are first-order:\n$$\n\\frac{dm}{dt} = \\frac{m_\\infty(V) - m}{\\tau_m},\n$$\nwith steady-state activation\n$$\nm_\\infty(V) = \\frac{1}{1 + \\exp\\!\\left( - \\frac{V - V_{1/2}}{k} \\right)},\n$$\nwhere $V_{1/2}$ is the half-activation voltage (in $\\text{mV}$), $k$ is the slope factor (in $\\text{mV}$), and $\\tau_m$ is the activation time constant (assumed voltage-independent in the repolarization regime and expressed in $\\text{ms}$). The derivative of the steady-state activation with respect to voltage is\n$$\n\\frac{d m_\\infty}{dV} = \\frac{1}{k}\\, m_\\infty(V)\\, \\left(1 - m_\\infty(V)\\right).\n$$\n\nDefine a representative voltage in the repolarization phase $V^\\* = 20\\,\\text{mV}$ and approximate $m^\\* = m_\\infty(V^\\*)$ at that voltage. Perform a linearization of the system $\\left(V, m\\right)$ around $\\left(V^\\*, m^\\*\\right)$ to obtain the Jacobian matrix $J$. Using the Jacobian eigenvalues $\\lambda_i$, define the dominant repolarization time constant as\n$$\n\\tau = -\\frac{1}{\\max\\limits_i \\Re\\left(\\lambda_i\\right)},\n$$\nwith the convention that $\\tau$ is expressed in $\\text{ms}$.\n\nA gain-of-function mutation in KCNC3 is modeled by parametric changes to the Kv3.3 channel:\n- Conductance scaling: $g_{Kv3}' = \\gamma \\cdot g_{Kv3}$ with $\\gamma \\geq 1$,\n- Half-activation shift: $V_{1/2}' = V_{1/2} + \\Delta$ with $\\Delta$ in $\\text{mV}$,\n- Kinetic acceleration: $\\tau_m' = \\phi \\cdot \\tau_m$ with $\\phi \\leq 1$.\n\nUse the following fixed baseline biophysical parameters for the wild-type channel and membrane:\n- $C_m = 1.0\\,\\mu \\text{F}/\\text{cm}^2$,\n- $g_L = 0.1\\,\\text{mS}/\\text{cm}^2$,\n- $E_L = -65\\,\\text{mV}$,\n- $E_K = -90\\,\\text{mV}$,\n- $g_{Kv3} = 10.0\\,\\text{mS}/\\text{cm}^2$,\n- $V_{1/2} = -10.0\\,\\text{mV}$,\n- $k = 10.0\\,\\text{mV}$,\n- $p = 4$,\n- $\\tau_m = 1.0\\,\\text{ms}$,\n- $V^\\* = 20.0\\,\\text{mV}$.\n\nConstruct the Jacobian $J$ at $\\left(V^\\*, m^\\*\\right)$ using the mutated parameters and compute the eigenvalues. Then, compute the dominant repolarization time constant $\\tau$ as defined above.\n\nTest Suite:\nCompute $\\tau$ for each of the following parameter sets $\\left(\\gamma, \\Delta, \\phi\\right)$ representing different gain-of-function scenarios:\n1. Wild-type control: $\\left(1.0,\\, 0.0,\\, 1.0\\right)$,\n2. Mild gain-of-function: $\\left(1.3,\\, -5.0,\\, 0.7\\right)$,\n3. Strong gain-of-function: $\\left(2.0,\\, -15.0,\\, 0.5\\right)$,\n4. Extreme gain-of-function: $\\left(3.5,\\, -30.0,\\, 0.3\\right)$,\n5. Activation-shift focused gain-of-function: $\\left(1.0,\\, -20.0,\\, 0.4\\right)$.\n\nAnswer Specification:\n- For each test case, output the dominant repolarization time constant $\\tau$ in $\\text{ms}$ as a floating-point number.\n- Your program should produce a single line of output containing the results as a comma-separated list enclosed in square brackets, with each value rounded to six decimal places, for example: $\\left[\\tau_1,\\tau_2,\\tau_3,\\tau_4,\\tau_5\\right]$.", "solution": "The problem statement has been critically examined and is determined to be valid. It is scientifically grounded in the Hodgkin-Huxley formalism, mathematically well-posed with a complete set of parameters and definitions, and articulated with objective, formal language. The task is to analyze a simplified biophysical model of a neuron, which is a standard procedure in computational neuroscience. All conditions for a valid problem are met.\n\nThe solution proceeds by linearizing the given system of differential equations around a specified point in its state space. The dominant repolarization time constant is then calculated from the eigenvalues of the resulting Jacobian matrix.\n\nThe system is described by a set of two coupled first-order ordinary differential equations for the membrane potential $V(t)$ and the potassium channel activation gating variable $m(t)$:\n$$\n\\begin{cases}\n\\dot{V} = f(V, m) = \\frac{1}{C_m} \\left[ -g_L \\left(V - E_L\\right) - g_{Kv3}\\, m^p \\left(V - E_K\\right) \\right] \\\\\n\\dot{m} = g(V, m) = \\frac{m_\\infty(V) - m}{\\tau_m}\n\\end{cases}\n$$\nWe linearize this system around the point $(V^*, m^*)$, where $V^*$ is the given representative repolarization voltage and $m^* = m_\\infty(V^*)$. The linearized system is described by the Jacobian matrix $J$ evaluated at this point:\n$$\nJ =\n\\begin{pmatrix}\n\\frac{\\partial f}{\\partial V} & \\frac{\\partial f}{\\partial m} \\\\\n\\frac{\\partial g}{\\partial V} & \\frac{\\partial g}{\\partial m}\n\\end{pmatrix}_{\\!(V^*, m^*)}\n$$\nThe partial derivatives required for the Jacobian matrix are calculated as follows:\n$$\n\\frac{\\partial f}{\\partial V} = \\frac{\\partial}{\\partial V} \\left( \\frac{1}{C_m} \\left[ -g_L V + g_L E_L - g_{Kv3} m^p V + g_{Kv3} m^p E_K \\right] \\right) = \\frac{1}{C_m} \\left( -g_L - g_{Kv3} m^p \\right)\n$$\n$$\n\\frac{\\partial f}{\\partial m} = \\frac{\\partial}{\\partial m} \\left( \\frac{1}{C_m} \\left[ -g_L \\left(V - E_L\\right) - g_{Kv3} m^p \\left(V - E_K\\right) \\right] \\right) = -\\frac{g_{Kv3} p m^{p-1}}{C_m} \\left(V - E_K\\right)\n$$\n$$\n\\frac{\\partial g}{\\partial V} = \\frac{\\partial}{\\partial V} \\left( \\frac{m_\\infty(V) - m}{\\tau_m} \\right) = \\frac{1}{\\tau_m} \\frac{d m_\\infty}{dV} = \\frac{1}{\\tau_m k} m_\\infty(V) \\left(1 - m_\\infty(V)\\right)\n$$\n$$\n\\frac{\\partial g}{\\partial m} = \\frac{\\partial}{\\partial m} \\left( \\frac{m_\\infty(V) - m}{\\tau_m} \\right) = -\\frac{1}{\\tau_m}\n$$\nThese derivatives are evaluated at $(V^*, m^*)$. To account for gain-of-function mutations, we introduce the scaling parameters $(\\gamma, \\Delta, \\phi)$ which modify the baseline parameters:\n$$\ng_{Kv3}' = \\gamma \\cdot g_{Kv3}\n$$\n$$\nV_{1/2}' = V_{1/2} + \\Delta\n$$\n$$\n\\tau_m' = \\phi \\cdot \\tau_m\n$$\nThe steady-state activation at $V^*$ is calculated using the shifted half-activation voltage $V_{1/2}'$:\n$$\nm^* = m_\\infty(V^*) = \\frac{1}{1 + \\exp\\!\\left( - \\frac{V^* - V_{1/2}'}{k} \\right)}\n$$\nSubstituting the mutated parameters and evaluating at $(V^*, m^*)$, the components of the Jacobian matrix $J$ are:\n$$\nJ_{11} = \\frac{1}{C_m} \\left( -g_L - g_{Kv3}' (m^*)^p \\right)\n$$\n$$\nJ_{12} = -\\frac{g_{Kv3}' p (m^*)^{p-1}}{C_m} \\left(V^* - E_K\\right)\n$$\n$$\nJ_{21} = \\frac{1}{\\tau_m' k} m^* \\left(1 - m^*\\right)\n$$\n$$\nJ_{22} = -\\frac{1}{\\tau_m'}\n$$\nFor each test case defined by a specific set of $(\\gamma, \\Delta, \\phi)$, we construct this $2 \\times 2$ matrix $J$. The eigenvalues $\\lambda_i$ of $J$ determine the time scales of the system's dynamics near the linearization point. The system repolarizes stably, so the real parts of the eigenvalues, $\\Re(\\lambda_i)$, will be negative. The dominant (i.e., slowest) time constant corresponds to the eigenvalue with the real part of smallest magnitude (closest to zero). This is found by taking the maximum of the real parts. The dominant repolarization time constant $\\tau$ is defined as:\n$$\n\\tau = -\\frac{1}{\\max\\limits_i \\Re\\left(\\lambda_i\\right)}\n$$\nThe computational procedure for each test case is therefore:\n1.  Update the parameters $g_{Kv3}$, $V_{1/2}$, and $\\tau_m$ using the given $(\\gamma, \\Delta, \\phi)$.\n2.  Calculate the value of $m^*$ at $V^* = 20.0\\,\\text{mV}$ using the updated $V_{1/2}'$.\n3.  Assemble the four components of the Jacobian matrix $J$ using the updated parameters.\n4.  Compute the two eigenvalues, $\\lambda_1$ and $\\lambda_2$, of the matrix $J$.\n5.  Find the maximum of their real parts, $\\lambda_{dom} = \\max(\\Re(\\lambda_1), \\Re(\\lambda_2))$.\n6.  Calculate the dominant time constant $\\tau = -1 / \\lambda_{dom}$.\n\nThis procedure is implemented for each of the five specified test cases to generate the final results.", "answer": "```python\nimport numpy as np\n\ndef solve():\n    \"\"\"\n    Computes the dominant repolarization time constant for a simplified\n    neuron model based on Hodgkin-Huxley kinetics for different KCNC3\n    channel mutation scenarios.\n    \"\"\"\n\n    # --- Fixed baseline biophysical parameters ---\n    Cm = 1.0       # Membrane capacitance (uF/cm^2)\n    gL = 0.1       # Leak conductance (mS/cm^2)\n    EL = -65.0     # Leak reversal potential (mV)\n    EK = -90.0     # Potassium reversal potential (mV)\n    g_kv3_base = 10.0  # Maximal Kv3.3 conductance (mS/cm^2)\n    V_half_base = -10.0  # Half-activation voltage (mV)\n    k = 10.0       # Slope factor (mV)\n    p = 4          # Cooperativity exponent (dimensionless)\n    tau_m_base = 1.0   # Activation time constant (ms)\n    V_star = 20.0    # Representative repolarization voltage (mV)\n\n    # --- Test suite: (gamma, Delta, phi) ---\n    test_cases = [\n        # 1. Wild-type control\n        (1.0, 0.0, 1.0),\n        # 2. Mild gain-of-function\n        (1.3, -5.0, 0.7),\n        # 3. Strong gain-of-function\n        (2.0, -15.0, 0.5),\n        # 4. Extreme gain-of-function\n        (3.5, -30.0, 0.3),\n        # 5. Activation-shift focused gain-of-function\n        (1.0, -20.0, 0.4),\n    ]\n\n    results = []\n    \n    for gamma, delta, phi in test_cases:\n        # Step 1: Apply mutational changes to parameters\n        g_kv3_prime = gamma * g_kv3_base\n        V_half_prime = V_half_base + delta\n        tau_m_prime = phi * tau_m_base\n\n        # Step 2: Calculate steady-state activation m* at V*\n        m_star_arg = -(V_star - V_half_prime) / k\n        m_star = 1.0 / (1.0 + np.exp(m_star_arg))\n\n        # Step 3: Assemble the Jacobian matrix J\n        # J = [[J11, J12], [J21, J22]]\n        J11 = (1.0 / Cm) * (-gL - g_kv3_prime * (m_star**p))\n        J12 = (-1.0 / Cm) * (g_kv3_prime * p * (m_star**(p - 1)) * (V_star - EK))\n        J21 = (1.0 / (tau_m_prime * k)) * m_star * (1.0 - m_star)\n        J22 = -1.0 / tau_m_prime\n\n        J = np.array([[J11, J12], [J21, J22]])\n\n        # Step 4: Compute the eigenvalues of J\n        eigenvalues = np.linalg.eigvals(J)\n\n        # Step 5: Find the maximum of the real parts of the eigenvalues\n        max_real_eigenvalue = np.max(np.real(eigenvalues))\n\n        # Step 6: Calculate the dominant time constant tau\n        tau = -1.0 / max_real_eigenvalue\n        results.append(tau)\n\n    # Format and print the final output\n    # Results are rounded to six decimal places.\n    print(f\"[{','.join(f'{res:.6f}' for res in results)}]\")\n\nsolve()\n```", "id": "4527255"}, {"introduction": "A hallmark of cerebellar dysfunction in many SCAs is the inability to maintain a steady gaze, resulting in gaze-evoked nystagmus. This exercise uses a classic control-theory model to explore the underlying mechanism: a \"leaky\" neural integrator for eye position in the brainstem, which is normally compensated for by the cerebellum [@problem_id:4527323]. You will mathematically model how a reduction in Purkinje cell output, a common pathological feature, compromises this compensation, leading to a quantifiable eye drift that explains the nystagmus. This practice offers a powerful example of how systems-level modeling can provide a clear, quantitative link between cellular pathology and a key clinical sign.", "problem": "You are tasked with constructing a minimal vestibulocerebellar circuit model, grounded in fundamental control and neurophysiology principles, to predict the amplitude of gaze-evoked nystagmus during eccentric gaze fixation in the context of spinocerebellar ataxias. The clinical scenario is floccular dysfunction leading to reduced Purkinje cell output. You must formalize the model mathematically and implement an algorithm that computes the corrective saccade amplitude (the fast-phase of the nystagmus) resulting from a leaky ocular motor neural integrator.\n\nFundamental base to use:\n1. The ocular motor neural integrator in the brainstem (vestibular nucleus) can be modeled as a linear time-invariant leaky integrator for eye position $E(t)$, with a decay constant $k$ (in $\\mathrm{s}^{-1}$). The leaky integrator dynamics between saccades are represented by the ordinary differential equation $dE/dt = -k E$ under a constant desired gaze command.\n2. The vestibulocerebellar flocculus provides inhibitory Purkinje cell output that effectively cancels a fraction of the brainstem integrator leak through negative feedback. In spinocerebellar ataxias, floccular Purkinje cell output is reduced, weakening that cancellation. Let the uncancelled brainstem leak be $k_0$ (in $\\mathrm{s}^{-1}$), and the fraction of leak canceled by intact floccular output be $g_{\\mathrm{pc}}$ (dimensionless, $0 \\le g_{\\mathrm{pc}} \\le 1$). A reduction of floccular Purkinje cell output by a fraction $r$ (expressed as a decimal, e.g., $r = 0.30$ for a thirty-percent reduction) scales down the cancellation proportionally.\n3. Solutions of linear differential equations with constant coefficients must be derived from first principles: for $dE/dt = -k E$ with initial condition $E(0) = E_0$, the solution is an exponential decay $E(t) = E_0 e^{-k t}$.\n\nOperational definition to implement:\n- Consider steady fixation at an eccentric target position $X_{\\mathrm{target}}$ (in degrees). Due to the leaky integrator, the eye position $E(t)$ drifts toward zero between corrective saccades. Corrective saccades are assumed to occur periodically every $T$ seconds, fully resetting $E$ to $X_{\\mathrm{target}}$ at the beginning of each cycle. The gaze-evoked nystagmus amplitude is defined as the magnitude of this corrective saccade, expressed in degrees.\n- You must derive, from the above base, an explicit expression for the effective leak $k_{\\mathrm{eff}}$ as a function of $k_0$, $g_{\\mathrm{pc}}$, and $r$, and then the corrective saccade amplitude as a function of $k_{\\mathrm{eff}}$, $X_{\\mathrm{target}}$, and $T$.\n\nScientific realism constraints:\n- Angles must be expressed in degrees.\n- Time must be expressed in seconds.\n- The floccular Purkinje cell reduction must be expressed as a decimal fraction (no percent sign is allowed).\n\nYour program must compute the nystagmus amplitude (in degrees) for each test case below and produce the outputs rounded to three decimal places.\n\nTest suite:\n- Case $1$: $k_0 = 1.00$ $\\mathrm{s}^{-1}$, $g_{\\mathrm{pc}} = 0.90$, $r = 0.00$, $X_{\\mathrm{target}} = 10.0$ degrees, $T = 0.50$ seconds. (Baseline with intact flocculus.)\n- Case $2$: $k_0 = 1.00$ $\\mathrm{s}^{-1}$, $g_{\\mathrm{pc}} = 0.90$, $r = 0.30$, $X_{\\mathrm{target}} = 10.0$ degrees, $T = 0.50$ seconds. (Thirty-percent reduction in Purkinje output.)\n- Case $3$: $k_0 = 1.00$ $\\mathrm{s}^{-1}$, $g_{\\mathrm{pc}} = 0.90$, $r = 0.30$, $X_{\\mathrm{target}} = 25.0$ degrees, $T = 0.50$ seconds. (Larger eccentricity.)\n- Case $4$: $k_0 = 1.00$ $\\mathrm{s}^{-1}$, $g_{\\mathrm{pc}} = 0.90$, $r = 0.30$, $X_{\\mathrm{target}} = 25.0$ degrees, $T = 0.25$ seconds. (Higher beat frequency.)\n- Case $5$: $k_0 = 1.00$ $\\mathrm{s}^{-1}$, $g_{\\mathrm{pc}} = 0.90$, $r = 0.30$, $X_{\\mathrm{target}} = 2.0$ degrees, $T = 0.50$ seconds. (Near-primary gaze.)\n\nYour program should produce a single line of output containing the results as a comma-separated list enclosed in square brackets (for example, $[a_1,a_2,a_3,a_4,a_5]$), where each $a_i$ is the predicted amplitude in degrees for the corresponding test case, rounded to three decimal places.", "solution": "The problem statement is assessed to be valid. It is scientifically grounded in established principles of neuroscience and control theory, well-posed with a complete and consistent set of parameters and objectives, and expressed in objective, formal language. The model is a standard and appropriate simplification used in computational neuroscience to study oculomotor deficits. The provided parameters are within physically and physiologically realistic ranges.\n\nThe solution proceeds by deriving the necessary mathematical expressions from the fundamental principles provided.\n\n### Step 1: Derivation of the Effective Leak Constant ($k_{\\mathrm{eff}}$)\n\nThe problem defines a hierarchy of effects contributing to the final, or effective, leak of the ocular motor neural integrator. We formalize this step-by-step.\n\n1.  **Baseline Leak**: The brainstem integrator has an inherent, uncancelled leak characterized by the constant $k_0$, with units of $\\mathrm{s}^{-1}$. This represents the tendency of the neural firing rates encoding eye position to decay toward a baseline.\n\n2.  **Healthy Cerebellar Compensation**: The vestibulocerebellar flocculus provides an inhibitory signal that cancels a fraction, $g_{\\mathrm{pc}}$, of this baseline leak. The magnitude of the leak being cancelled is therefore the product $k_0 g_{\\mathrm{pc}}$. In a perfectly healthy system (where the reduction fraction $r=0$), the net leak constant is the baseline leak minus the compensated portion:\n    $$k_{\\mathrm{healthy}} = k_0 - k_0 g_{\\mathrm{pc}} = k_0(1 - g_{\\mathrm{pc}})$$\n\n3.  **Pathological Decompensation**: In spinocerebellar ataxia, floccular Purkinje cell output is reduced by a fraction $r$. This means the compensatory mechanism is only $(1-r)$ times as effective as it is in the healthy state. The amount of leak cancelled is now reduced to $(1-r) k_0 g_{\\mathrm{pc}}$.\n\n4.  **Effective Leak Constant ($k_{\\mathrm{eff}}$)**: The effective leak constant, $k_{\\mathrm{eff}}$, in the pathological state is the baseline leak, $k_0$, minus this reduced compensatory cancellation.\n    $$k_{\\mathrm{eff}} = k_0 - (1-r) k_0 g_{\\mathrm{pc}}$$\n    Factoring out $k_0$ yields the general expression for the effective leak constant as a function of the given parameters:\n    $$k_{\\mathrm{eff}} = k_0 (1 - (1-r)g_{\\mathrm{pc}})$$\n    This formula correctly captures the limiting cases: a healthy system ($r=0$) results in $k_{\\mathrm{eff}} = k_0(1-g_{\\mathrm{pc}})$, and a complete loss of cerebellar compensation ($r=1$ or $g_{pc}=0$) results in $k_{\\mathrm{eff}}=k_0$.\n\n### Step 2: Derivation of the Corrective Saccade Amplitude ($A$)\n\nThe amplitude of the corrective saccade is determined by how far the eye drifts from the target during the inter-saccadic interval.\n\n1.  **Eye Position Dynamics**: Between saccades, the eye position $E(t)$ is governed by the leaky integrator differential equation with the effective leak constant $k_{\\mathrm{eff}}$:\n    $$\\frac{dE}{dt} = -k_{\\mathrm{eff}} E(t)$$\n\n2.  **Initial Condition**: The cycle begins at time $t=0$, immediately following a corrective saccade that has placed the eye on the eccentric target. The initial position is therefore $E(0) = X_{\\mathrm{target}}$.\n\n3.  **Solution of the ODE**: The solution to this first-order linear ordinary differential equation with the given initial condition is an exponential decay:\n    $$E(t) = E(0) e^{-k_{\\mathrm{eff}} t} = X_{\\mathrm{target}} e^{-k_{\\mathrm{eff}} t}$$\n\n4.  **Eye Drift**: A corrective saccade is triggered after a time interval $T$. At this moment, just before the saccade, the eye has drifted to the position $E(T)$:\n    $$E(T) = X_{\\mathrm_{\\text{target}}} e^{-k_{\\mathrm{eff}} T}$$\n    The total displacement, or drift, from the target is the difference between the target position and the position at time $T$:\n    $$\\Delta E = X_{\\mathrm{target}} - E(T) = X_{\\mathrm{target}} - X_{\\mathrm{target}} e^{-k_{\\mathrm{eff}} T}$$\n\n5.  **Saccade Amplitude ($A$)**: The corrective saccade has an amplitude, $A$, equal to the magnitude of this drift, as it must move the eye from $E(T)$ back to $X_{\\mathrm_{\\text{target}}}$.\n    $$A = |\\Delta E| = |X_{\\mathrm{target}} (1 - e^{-k_{\\mathrm{eff}} T})|$$\n    Since $X_{\\mathrm{target}}$, $k_{\\mathrm{eff}}$, and $T$ are all non-negative, the expression within the absolute value is also non-negative. The final expression for the nystagmus amplitude is:\n    $$A = X_{\\mathrm{target}} (1 - e^{-k_{\\mathrm{eff}} T})$$\n\n### Step 3: Computational Algorithm\n\nThe final algorithm combines these two derived expressions. For each test case, specified by the set of parameters $\\{k_0, g_{\\mathrm{pc}}, r, X_{\\mathrm{target}}, T\\}$, the corrective saccade amplitude $A$ is computed as follows:\n1.  Calculate the effective leak constant $k_{\\mathrm{eff}}$ using $k_{\\mathrm{eff}} = k_0 (1 - (1-r)g_{\\mathrm{pc}})$.\n2.  Calculate the amplitude $A$ using $A = X_{\\mathrm{target}} (1 - e^{-k_{\\mathrm{eff}} T})$.\n3.  Round the resulting amplitude $A$ to three decimal places.\nThis procedure is implemented in the following Python code to solve for the provided test cases.", "answer": "```python\n# The complete and runnable Python 3 code goes here.\n# Imports must adhere to the specified execution environment.\nimport numpy as np\n\ndef solve():\n    \"\"\"\n    Computes the gaze-evoked nystagmus amplitude based on a minimal\n    vestibulocerebellar circuit model.\n    \"\"\"\n    # Define the test cases from the problem statement as a list of tuples.\n    # Each tuple contains: (k0, g_pc, r, X_target, T)\n    test_cases = [\n        # Case 1: Baseline with intact flocculus.\n        (1.00, 0.90, 0.00, 10.0, 0.50),\n        # Case 2: Thirty-percent reduction in Purkinje output.\n        (1.00, 0.90, 0.30, 10.0, 0.50),\n        # Case 3: Larger eccentricity.\n        (1.00, 0.90, 0.30, 25.0, 0.50),\n        # Case 4: Higher beat frequency.\n        (1.00, 0.90, 0.30, 25.0, 0.25),\n        # Case 5: Near-primary gaze.\n        (1.00, 0.90, 0.30, 2.0, 0.50),\n    ]\n\n    results = []\n    for case in test_cases:\n        k0, g_pc, r, X_target, T = case\n\n        # Step 1: Calculate the effective leak constant (k_eff).\n        # This represents the net leak of the ocular motor integrator after\n        # accounting for the pathologically reduced cerebellar compensation.\n        # Formula: k_eff = k0 * (1 - (1 - r) * g_pc)\n        k_eff = k0 * (1.0 - (1.0 - r) * g_pc)\n\n        # Step 2: Calculate the nystagmus amplitude (A).\n        # This is the magnitude of the drift of the eye away from the target\n        # over the inter-saccadic interval T, which must be corrected by a saccade.\n        # Formula: A = X_target * (1 - exp(-k_eff * T))\n        amplitude = X_target * (1.0 - np.exp(-k_eff * T))\n\n        # Append the result, rounded to three decimal places, to the list.\n        results.append(round(amplitude, 3))\n\n    # Final print statement in the exact required format: a single-line string\n    # of a comma-separated list of results enclosed in square brackets.\n    print(f\"[{','.join(map(str, results))}]\")\n\n# Execute the solver function.\nsolve()\n```", "id": "4527323"}, {"introduction": "Understanding the genetic burden of a disease within a population is a critical aspect of medical genetics and public health. This practice applies the fundamental principles of Hardy-Weinberg equilibrium to the study of autosomal dominant SCAs [@problem_id:4527257]. You will derive and apply a crucial relationship that connects an observable epidemiological measure, disease prevalence ($\\pi$), to the underlying population carrier frequency ($C$), demonstrating how incomplete penetrance ($f$) must be accounted for in disorders with age-dependent manifestation. This exercise solidifies the skills needed to interpret population-level data for genetic counseling and epidemiological studies.", "problem": "Spinocerebellar ataxia (SCA) is commonly inherited in an autosomal dominant manner, with many subtypes exhibiting age-dependent penetrance due to variable repeat lengths and neurodegenerative progression. Consider a single autosomal dominant SCA locus with a disease allele denoted by $D$ and a wild-type allele denoted by $N$. Assume a large, randomly mating population in Hardy–Weinberg equilibrium (HWE), absence of assortative mating with respect to genotype at this locus, no de novo mutational influx over the time scale of interest, and no phenocopies in the age stratum considered. Let the allele frequencies be $p$ for $N$ and $q$ for $D$, with $p+q=1$, and let the age-specific clinical penetrance (the probability that an individual carrying at least one copy of $D$ manifests SCA in this age stratum) be $f$. The genotype frequencies under HWE are $p^{2}$ for $NN$, $2 p q$ for $ND$, and $q^{2}$ for $DD$. Let the age-specific prevalence of clinically manifest SCA due to this allele in this population be $\\pi$.\n\nStarting from these definitions and assumptions, derive an expression for the carrier frequency $C$ (the proportion of individuals in the population who carry at least one copy of $D$) in terms of $\\pi$ and $f$, clearly justifying each step from first principles and the HWE framework. Then use this expression to estimate $C$ for the following empirically observed values in the age stratum of interest: $\\pi = 3.75 \\times 10^{-5}$ and $f = 0.80$. Round your final numerical answer for $C$ to four significant figures. Express the final answer as a pure number with no units.", "solution": "The problem will be validated before a solution is attempted.\n\n### Step 1: Extract Givens\nThe following information is provided in the problem statement:\n- **Disease Model:** Spinocerebellar ataxia (SCA) inherited in an autosomal dominant manner.\n- **Alleles:** Disease allele $D$, wild-type allele $N$.\n- **Population Assumptions:** Large, randomly mating population in Hardy–Weinberg equilibrium (HWE); absence of assortative mating; no de novo mutational influx; no phenocopies.\n- **Allele Frequencies:** $p$ for allele $N$ and $q$ for allele $D$, with the constraint $p+q=1$.\n- **Genotype Frequencies (HWE):** $p^{2}$ for $NN$, $2pq$ for $ND$, and $q^{2}$ for $DD$.\n- **Penetrance ($f$):** The age-specific clinical penetrance, defined as the probability that an individual carrying at least one copy of $D$ manifests SCA.\n- **Prevalence ($\\pi$):** The age-specific prevalence of clinically manifest SCA due to this allele.\n- **Carrier Frequency ($C$):** The proportion of individuals in the population who carry at least one copy of $D$.\n- **Empirical Values:** $\\pi = 3.75 \\times 10^{-5}$ and $f = 0.80$.\n- **Task:** 1) Derive an expression for $C$ in terms of $\\pi$ and $f$. 2) Estimate $C$ using the given values, rounded to four significant figures.\n\n### Step 2: Validate Using Extracted Givens\nThe problem statement is evaluated against the validation criteria:\n- **Scientifically Grounded:** The problem is based on fundamental principles of population genetics, specifically the Hardy-Weinberg equilibrium, autosomal dominant inheritance, and the concepts of penetrance and prevalence. These are standard and well-established concepts in medical genetics and biology. The context of spinocerebellar ataxia is scientifically appropriate.\n- **Well-Posed:** All terms ($C$, $\\pi$, $f$, $p$, $q$) are clearly defined. The relationships between them are governed by the assumptions of HWE and the probabilistic nature of the definitions. The problem provides sufficient information to derive the required expression and calculate the numerical value. A unique solution exists.\n- **Objective:** The language is precise, quantitative, and free of subjective or ambiguous statements.\n- **Completeness and Consistency:** The problem is self-contained. The assumptions (e.g., \"no phenocopies\") are crucial and clearly stated. There are no internal contradictions. For instance, the genotype frequencies sum to $p^2 + 2pq + q^2 = (p+q)^2 = 1^2 = 1$, which is consistent.\n- **Realism:** The scenario is a realistic application of population genetics to estimate disease allele carrier frequency from epidemiological data (prevalence and penetrance). The given numerical values are plausible for a rare genetic disorder.\n\n### Step 3: Verdict and Action\nThe problem is scientifically sound, well-posed, and objective. It is deemed **valid**. A solution will be provided.\n\n### Solution Derivation\n\nThe problem requires deriving an expression for the carrier frequency, $C$, in terms of the prevalence, $\\pi$, and penetrance, $f$. We begin by formalizing the provided definitions using probability theory. Let us consider a randomly selected individual from the population.\n\nLet $A$ be the event that the individual is clinically affected (i.e., manifests SCA).\nLet $K$ be the event that the individual is a carrier of the disease allele $D$ (i.e., has genotype $ND$ or $DD$).\n\nFrom the problem statement, we can directly translate the definitions into probabilistic terms:\n- The prevalence, $\\pi$, is the probability of being affected: $\\pi = P(A)$.\n- The carrier frequency, $C$, is the probability of being a carrier: $C = P(K)$.\n- The penetrance, $f$, is the probability that a carrier is affected. This is a conditional probability: $f = P(A|K)$.\n\nThe framework of Hardy-Weinberg equilibrium gives the frequencies of the genotypes. The carriers are individuals with genotype $ND$ or $DD$. Therefore, the carrier frequency $C$ is the sum of the frequencies of these two genotypes:\n$$C = \\text{freq}(ND) + \\text{freq}(DD) = 2pq + q^2$$\n\nThe problem makes a critical assumption of \"no phenocopies\". This means that an individual can manifest the disease *only if* they are a carrier of the allele $D$. In terms of our events, this implies that the event $A$ (being affected) is a sub-event of the event $K$ (being a carrier). Consequently, if event $A$ occurs, event $K$ must also occur. This means the intersection of the two events, $A \\cap K$, is identical to the event $A$ itself.\n$$A \\cap K = A$$\nTherefore, the probability of the intersection is simply the probability of event $A$:\n$$P(A \\cap K) = P(A) = \\pi$$\n\nThe definition of conditional probability for $f = P(A|K)$ is:\n$$f = P(A|K) = \\frac{P(A \\cap K)}{P(K)}$$\n\nSubstituting our defined terms and the result from the \"no phenocopies\" assumption into this equation:\n$$f = \\frac{\\pi}{C}$$\n\nThis equation provides a direct relationship between penetrance, prevalence, and carrier frequency. We can now rearrange this expression to solve for the carrier frequency, $C$, as requested by the problem:\n$$C = \\frac{\\pi}{f}$$\nThis completes the first part of the task. This expression is derived from first principles based on the provided definitions and assumptions.\n\n### Numerical Estimation\n\nThe second part of the task is to estimate $C$ using the given empirical values: $\\pi = 3.75 \\times 10^{-5}$ and $f = 0.80$.\n\nSubstituting these values into our derived expression:\n$$C = \\frac{3.75 \\times 10^{-5}}{0.80}$$\n\nPerforming the division:\n$$C = \\frac{3.75}{0.80} \\times 10^{-5} = 4.6875 \\times 10^{-5}$$\n\nThe problem requires the final answer to be rounded to four significant figures. The first four significant figures are $4$, $6$, $8$, and $7$. The fifth significant figure is $5$, which requires rounding up the fourth digit.\n$$C \\approx 4.688 \\times 10^{-5}$$\n\nThis is the estimated carrier frequency for the SCA allele in the population of interest.", "answer": "$$\\boxed{4.688 \\times 10^{-5}}$$", "id": "4527257"}]}